Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation
about
NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cellsStructure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cellsFibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesisStructure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifenExtracts of strawberry fruits induce intrinsic pathway of apoptosis in breast cancer cells and inhibits tumor progression in miceEquol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells.The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approachesThe new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.Short-term primary culture of epithelial cells derived from human breast tumoursMethylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells.Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell line.Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells.Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix.Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer.Prediction of hormone sensitivity for breast cancers.A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes.Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12.NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.Protein kinase C α enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin.Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
P2860
Q24313517-C7820D98-D0A9-4925-BB6E-F50C5FBFC911Q28343990-3A9C28A0-BB2A-4389-8CF2-603C21251AE5Q33739802-65D54835-9291-49B2-B99D-25CE1A07FD58Q33743983-4DE46D53-6E97-47AB-9186-3A38296E8615Q33779406-6DBC34D4-938A-4B20-9C4E-52EC39510B32Q33841524-4405060E-8A57-44E8-95A7-DBD516E3BA50Q34447791-D3892824-3359-4649-BC34-EF1007B41AA0Q34723570-E6E34A07-818A-4174-8CBF-EC386674DEEFQ35275278-D7347EDE-4A68-4FB9-AE0E-3A32342F4DC3Q35652417-7B4C82BB-309C-4D7A-AD60-42DD511C1180Q35827822-E443CBD2-D8AF-4FA3-B682-B8123B2BF572Q36115787-C8A0558A-C7AD-432D-A3C5-0CE150DB5608Q36294864-263332F6-F5A4-458A-BC99-B530D9097AC6Q36419975-CC68646C-6158-4D52-837A-20E699B6131CQ36517144-60F53EDC-758A-4569-9BC2-61730D99BFE2Q36547484-E19E05A0-2318-4199-8E93-CE257FAD910EQ36621886-D059F8B9-4ACE-4F90-BE0D-7F44CEB6C865Q36684234-87714AA8-0D6E-431F-9FB6-01A8D092A345Q36919229-BC1848DD-46A5-4ED8-919B-CCAF760F0BFAQ37113821-013CC084-74FE-4823-B972-8F2BAE9D8784Q37137262-55CBA0CA-CBB6-4F5B-B80E-CD27EB45F29BQ37219226-C041BD68-D092-48C3-8C78-4C7E82E6D5F6Q37346786-35E92569-84C7-40FE-8670-88F808633FA8Q37531200-DF7235FD-B84D-423C-99BB-6CA5BBCE7589Q37608967-33439264-8859-49C2-97B6-BC6F7B8C4B5BQ38720232-D916242B-76E7-4672-A019-198784215E5DQ39022052-DFFFEDD4-7CF1-4A87-BC15-3AA72DE9C193Q40426955-F394556C-BF1E-40F1-ABD3-101B51220583Q40681909-D9EF3323-4F55-4643-8744-A5B7D1ED7BE7Q40899393-A51AA51C-1668-4BA2-9510-6BAFB78F8708Q46488696-21BAFE8B-A52C-44B3-BC2D-5CC0210A18A7Q49988930-60124EB1-48F4-45B0-91BD-ED053170C9F1Q55068164-17D56A7B-E5AE-47AF-9D31-E53F61F3D904
P2860
Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Irreversible loss of the oestr ...... rolonged oestrogen deprivation
@ast
Irreversible loss of the oestr ...... rolonged oestrogen deprivation
@en
type
label
Irreversible loss of the oestr ...... rolonged oestrogen deprivation
@ast
Irreversible loss of the oestr ...... rolonged oestrogen deprivation
@en
prefLabel
Irreversible loss of the oestr ...... rolonged oestrogen deprivation
@ast
Irreversible loss of the oestr ...... rolonged oestrogen deprivation
@en
P2093
P2860
P4510
P356
P1476
Irreversible loss of the oestr ...... rolonged oestrogen deprivation
@en
P2093
M M Bilimoria
V C Jordan
P2860
P2888
P304
P356
10.1038/BJC.1996.521
P407
P577
1996-10-01T00:00:00Z
P5875
P6179
1051725179